Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Daniel Q. Huang, Amit G. Singal, Yuko Kono, et al.
Cell Metabolism (2022) Vol. 34, Iss. 7, pp. 969-977.e2
Open Access | Times Cited: 328

Showing 1-25 of 328 citing articles:

The global burden of metabolic disease: Data from 2000 to 2019
Nicholas Chew, Cheng Han Ng, Darren Jun Hao Tan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 414-428.e3
Closed Access | Times Cited: 370
Global epidemiology of cirrhosis — aetiology, trends and predictions
Daniel Q. Huang, Norah A. Terrault, Frank Tacke, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 388-398
Open Access | Times Cited: 359
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S32-S42
Open Access | Times Cited: 307
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
Amit G. Singal, Fasiha Kanwal, Josep M. Llovet
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 12, pp. 864-884
Closed Access | Times Cited: 284
Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 271
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 267
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Yao‐Chun Hsu, Daniel Q. Huang, Mindie H. Nguyen
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 524-537
Closed Access | Times Cited: 248
Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 169
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 471-478
Open Access | Times Cited: 165
The role of hepatokines in NAFLD
Norbert Stefan, Fritz Schick, Andreas L. Birkenfeld, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 236-252
Open Access | Times Cited: 135
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 101
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 93
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
Darren Jun Hao Tan, Veronica Wendy Setiawan, Cheng Han Ng, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1150-1163
Open Access | Times Cited: 88
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
Yuanbin Liu, Mingkai Chen
World Journal of Gastroenterology (2022) Vol. 28, Iss. 41, pp. 5910-5930
Open Access | Times Cited: 86
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
Daniel Q. Huang, Laura Wilson, Cynthia Behling, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 463-472.e5
Open Access | Times Cited: 83
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 82
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Daniel Q. Huang, Nabil Noureddin, Veeral Ajmera, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 829-836
Open Access | Times Cited: 67
Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin
Rebecca Wenling Zeng, Jie Ning Yong, Darren Jun Hao Tan, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 6, pp. 600-609
Open Access | Times Cited: 58
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 53
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
Daniel Q. Huang, Andrew Tran, Ming‐Lun Yeh, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1558-1568
Closed Access | Times Cited: 49
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 48
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease
Rohit Loomba, Vincent Wai‐Sun Wong
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 2, pp. 150-156
Open Access | Times Cited: 48
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma
Takeshi Yokoo, Nobuaki Masaki, Neehar D. Parikh, et al.
Radiology (2023) Vol. 307, Iss. 2
Open Access | Times Cited: 43
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Do Young Kim
Journal of Liver Cancer (2024) Vol. 24, Iss. 1, pp. 622-70
Open Access | Times Cited: 42
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
James A. Thomas, Bradley J. Kendall, Hashem B. El‐Serag, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 159-169
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top